Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors

[1]  Hamidreza Zalpoor,et al.  Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases , 2022, Human Cell.

[2]  M. Liaghat,et al.  Quercetin potential effects against SARS‐CoV‐2 infection and COVID‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α (HIF‐1α) , 2022, Phytotherapy research : PTR.

[3]  Thomas E. Nichols,et al.  SARS-CoV-2 is associated with changes in brain structure in UK Biobank , 2022, Nature.

[4]  F. Heidari,et al.  The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies , 2022, Cellular & molecular biology letters.

[5]  S. Mukerji,et al.  Post-acute neurological consequences of COVID-19: an unequal burden , 2022, Nature Medicine.

[6]  M. J. van den Bent,et al.  Patients with primary brain tumors and COVID-19: A report from the Dutch Oncology COVID-19 Consortium , 2021, Neuro-oncology.

[7]  Xiaozhong Peng,et al.  Neurological complications and infection mechanism of SARS-CoV-2 , 2021, Signal Transduction and Targeted Therapy.

[8]  Shobi Veleri.  Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients , 2021, Experimental brain research.

[9]  M. Khezri,et al.  Neurological effects of elevated levels of angiotensin II in COVID-19 patients , 2021, Human Cell.

[10]  P. Chastagner,et al.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors , 2021, Frontiers in Oncology.

[11]  Endeshaw Chekol Abebe,et al.  Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target , 2021, Biologics : targets & therapy.

[12]  A. Engin,et al.  Current opinion in neurological manifestations of SARS-CoV-2 infection , 2021, Current Opinion in Toxicology.

[13]  Stephanie I. Shiers,et al.  Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain , 2021, Pain reports.

[14]  OUP accepted manuscript , 2021, Neuro-Oncology.

[15]  Liping Zhong,et al.  Targeting neuropilin-1 interactions is a promising anti-tumor strategy , 2020, Chinese medical journal.

[16]  G. Curigliano,et al.  Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies , 2020, European Journal of Cancer.

[17]  A. Helenius,et al.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system , 2020, bioRxiv.